ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

April 6, 1979

Sloan-Kettering Cited For 8 Violations Of NY State Standards

November 24, 1995

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

December 27, 2002

MAP Says It Will Continue Operating With Private Funds

April 18, 1986

For Frederick, Unseat Program Resources Inc.

March 3, 1995